Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc (NASDAQ: AMED) provides essential home healthcare, hospice, and high-acuity care services across the United States. This news hub offers investors and industry professionals direct access to verified corporate announcements and financial updates from the home healthcare leader.
Track material developments including quarterly earnings reports, regulatory filings, clinical program expansions, and strategic partnerships. Our curated collection features official press releases, SEC disclosures, and market-moving updates - all organized chronologically for efficient research.
Key content categories include financial performance updates, Medicare/Medicaid compliance changes, care center acquisitions, leadership appointments, and clinical quality initiatives. Bookmark this page for real-time access to operational milestones that shape AMED's position in the $300B home healthcare market.
For stakeholders monitoring the shift toward value-based care models, this resource simplifies tracking of Amedisys' evolving service offerings and regulatory compliance status. Visit regularly to stay informed about critical developments affecting one of America's largest home health providers.
Amedisys, Inc. (NASDAQ: AMED) has been recognized as one of the 2022 Best Places to Work in Healthcare by Modern Healthcare for the second consecutive year. This distinction highlights companies that empower employees to provide exceptional care. Amedisys emphasizes creating a supportive environment for its staff, crucial during the challenges posed by the pandemic. The evaluation involved 25% from company practices and 75% from employee engagement scores. The complete list of winners will be published on September 29, 2022.
Amedisys, a home health, hospice, and personal care provider, announced a series of upcoming investor presentations. CEO Chris Gerard and CFO Scott Ginn will present at the Bank of America Securities Healthcare Conference on May 10 at 5:40 p.m. ET, the RBC Capital Markets Global Healthcare Conference on May 17, and the UBS Global Healthcare Conference on May 23 at 9:15 a.m. ET. Investors can access a live webcast of these presentations through the company’s website.
Amedisys operates nationwide, serving over 445,000 patients annually with high-quality home-based care.
Amedisys, Inc. (NASDAQ: AMED) reported Q1 2022 financial results, showing a net service revenue increase of $8.2 million to $545.3 million but a decline in net income to $31.7 million from $49.9 million in 2021. Adjusted EBITDA was $66.3 million versus $78.6 million in the prior year. The company's guidance for 2022 includes anticipated adjusted revenue between $2.330 billion to $2.365 billion and adjusted diluted earnings per share of $5.23 to $5.45. CEO Chris Gerard highlighted challenges due to COVID-19 but expressed confidence in growth opportunities.
Amedisys, Inc. (NASDAQ: AMED) has promoted Nick Muscato to Chief Strategy Officer, effective immediately. Muscato has significant experience in the company, previously serving as Senior Vice President of Finance, and has been instrumental in developing the company's strategic direction. His efforts in Investor Relations have strengthened relationships with analysts and shareholders. Muscato expressed enthusiasm for continuing to enhance Amedisys’ mission of providing home-based healthcare services and improving patient care.
Amedisys, Inc. (NASDAQ: AMED) will announce its first-quarter results for the period ending March 31, 2022, after market hours on April 27, 2022. The company plans to host an investor conference call the following day at 11:00 a.m. ET to discuss these results. Interested participants can join the call via toll-free numbers or through the company's website. Amedisys specializes in home health, hospice, personal care, and high-acuity care, serving over 445,000 patients annually with more than 11.5 million visits in 38 states.
Amedisys has successfully acquired Evolution Health, enhancing its home health services footprint across Texas, Oklahoma, and Ohio. This acquisition allows Amedisys to operate under established local brands like Guardian Healthcare, expanding care options to more communities. The company now boasts 350 care centers across 34 states, servicing roughly 74,000 patients daily. Amedisys ranks as the second-largest home health provider and third-largest hospice provider in the U.S., with a commendable Quality of Patient Care (QPC) Star score of 4.33.
Amedisys, Inc. (NASDAQ: AMED) has acquired home health assets from AssistedCare Home Health and RH Homecare Services, enhancing its service offerings in North Carolina. This acquisition allows Amedisys to extend both home health and hospice services into new communities, particularly Wilmington and Greenville. With this addition, Amedisys operates 350 care centers across 34 states, serving around 74,000 patients daily. The company emphasizes its commitment to quality, holding a QPC Star score of 4.33 and recognition as a top workplace in healthcare.
Amedisys, a prominent provider of home health and hospice services, will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 16, 2022, at 10:40 a.m. EST, followed by the Barclays Global Healthcare Conference on March 17, 2022, at 8:00 a.m. EST. Key executives Chris Gerard and Scott Ginn will lead the presentations. Investors can access the live webcasts on Amedisys’ official website. With over 21,000 employees and 530 care centers across 38 states, Amedisys serves more than 445,000 patients annually, conducting over 11.5 million visits each year.
Amedisys, Inc. (NASDAQ: AMED), a prominent provider of home health and hospice services, announced its participation in the Raymond James & Associates' 43rd Annual Institutional Investors Conference. Chris Gerard, President and COO, along with Scott Ginn, CFO, will present on March 8 at 11:35 a.m. EST. Interested individuals can access the live webcast through Amedisys' investor relations website. The company, founded in 1982 and based in Baton Rouge, serves over 418,000 patients annually with a workforce of approximately 21,000 employees across 529 care centers in 38 states.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
